You are here

Drug's pricing proves a defining moment in modern healthcare

STRATEGIC MOVE? Mr Shkreli's company, Turing Pharmaceuticals, raised the price of Daraprim from US$13.50 to US$750 per pill because it could.


MARTIN Shkreli is healthcare's Gordon Gekko, its wolf of Wall Street, the symbol of all that makes people uneasy about an industry that seeks to make money by selling treatments while vowing to care only about the well-being of vulnerable patients.

For days, a seething